Group 1 - The cell immunotherapy sector experienced a significant rally in the afternoon, with Kaineng Health hitting a 20% limit up, and Jimin Health, Zhongyuan Qihe, and Nanjing Xinbai also previously reaching their limit up [1] - Sanyuan Gene saw an increase of over 10%, while Chengda Pharmaceutical and Sunshine Nuohe also followed the upward trend [1] - A recent research paper published in the journal Nature Biotechnology indicates that low-intensity ultrasound treatment can eliminate neurotoxic debris in the brains of mice induced with hemorrhagic stroke [1]

Group 1 - Kaineng Health will distribute a cash dividend of RMB 0.5 per 10 shares (including tax), with the record date on November 17, 2025, and the ex-dividend date on November 18, 2025 [1] - Siling Co. will distribute a cash dividend of RMB 2 per 10 shares (including tax), with the record date on November 17, 2025, and the ex-dividend date on November 18, 2025 [1] - Baolidi will distribute a cash dividend of RMB 2 per 10 shares (including tax), with the record date on November 18, 2025, and the ex-dividend date on November 19, 2025 [1] Group 2 - Kaineng Health is classified under the household appliances industry and is part of the non-dividend low volatility (H30269.CSI) and non-dividend quality (931468.CSI) indices [1] - Siling Co. is classified under the automotive industry and is part of the non-dividend low volatility (H30269.CSI) and non-dividend quality (931468.CSI) indices [1] - Baolidi is classified under the basic chemicals industry and is part of the non-dividend low volatility (H30269.CSI) and non-dividend quality (931468.CSI) indices [1]

一、审议通过利润分配方案等情况 1、2025年5月20日，开能健康科技集团股份有限公司（以下简称"公司"）召 开2024年年度股东大会，审议通过《关于董事会提请股东大会授权2025年度中期 分红的议案》，在不违反相关法律法规、规范性文件及《公司章程》等有关规定 的前提下，公司可以根据2025年经营情况，进行中期利润分配，派发现金红利总 金额不超过当期净利润，授权公司董事会制定具体的2025年中期分红方案并实施。 证券代码：300272 证券简称：开能健康 公告编号：2025-093 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、公司以最新总股本 611,469,472 股，按每股现金分红金额不变的原则，向 全体股东每 10 股派发现金股利人民币 0.5 元（含税），共计派现 30,573,473.60 元，不送红股，不以资本公积金转增股本。 2、股权登记日：2025 年 11 月 17 日；除权除息日：2025 年 11 月 18 日。 3、按公司最新总股本折算每 10 股现金分红=本次实际现金分红总额÷公司 总股本×10 股=30,573, ...

证券日报网讯11月10日晚间，开能健康（300272）发布公告称，本次公司注册资本变更事项的工商变更 登记手续已经办理完毕。2025年11月7日，公司领取了上海市市场监督管理局换发的《营业执照》。 ...

证券代码：300272 证券简称：开能健康 公告编号：2025-092 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、概况 根据中国证券监督委员会出具的《关于同意开能健康科技集团股份有限公司 向不特定对象发行可转换公司债券注册的批复》（证监许可〔2023〕1321号）， 同意开能健康科技集团股份有限公司（以下简称"公司"）向不特定对象发行可 转换公司债券250万张（债券简称：开能转债；债券代码：123206），开能转债 已于2023年8月8日上市，转股期为2024年1月26日至2029年7月19日。截止2025 年9月2日，公司"开能转债"已全部赎回，并于2025年9月9日披露了《关于开能 转债摘牌的公告》，公司注册资本已由57,717.5948万元增至61,146.9472万元。 2025年9月10日，公司召开第六届董事会第二十六次会议，审议通过了《关 于修订<公司章程>并办理公司注册资本变更登记的议案》，并经公司2025年9月 29日召开的2025年第二次临时股东大会审议通过。 二、变更完成情况 经营范围： 许可项目：燃气燃烧器具安装、维修；道路货物 ...

（编辑 王雪儿） 证券日报网讯 开能健康11月10日在互动平台回答投资者提问时表示，截至10月31日，公司股东户数为 22036户，公司管理层对未来发展充满信心，秉承稳健经营、坚持规范运作、围绕发展战略，公司将切 实履行信息披露义务、不断加强投资者沟通等多种方式，积极向市场传递公司投资价值，正股价格的涨 跌受多重因素影响而发生变化，公司将通过良好的经营给与股东稳定的回报，并继续加大和投资人的沟 通、交流和学习，使得投资者更加了解公司。 ...

Core Viewpoint - The company, Kangen Health, has stated that it remains at the forefront of the water purification market, with its main products achieving international advanced levels and its whole-house series products generating no wastewater loss [1] Company Summary - Kangen Health's main products in the water purification sector are recognized for their advanced technology, aligning with international standards [1] - The company's whole-house series products are designed to operate without generating wastewater, highlighting their efficiency and sustainability [1]

Market Overview - The small home appliance sector increased by 0.77% compared to the previous trading day, with Bi Yi Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] Stock Performance - Bi Yi Co., Ltd. (603215) closed at 21.05, up 3.34% with a trading volume of 69,500 shares and a turnover of 146 million yuan [1] - Other notable performers include: - Kai Neng Health (300272) at 6.91, up 2.98% [1] - Lek Electric (603355) at 25.95, up 2.57% [1] - Dechang Co., Ltd. (605555) at 19.53, up 2.04% [1] - ST Dehao (002005) at 2.73, up 1.49% [1] Capital Flow - The small home appliance sector saw a net inflow of 62.27 million yuan from institutional investors, while retail investors experienced a net outflow of 67.04 million yuan [2] - The main capital inflow was concentrated in Dechang Co., Ltd. with a net inflow of 46.16 million yuan [3] - Kai Neng Health also attracted significant institutional investment with a net inflow of 24.51 million yuan [3] Individual Stock Capital Flow - Bi Yi Co., Ltd. had a net inflow of 8.20 million yuan from institutional investors, but retail investors withdrew 39.75 million yuan [3] - Other stocks with notable capital flows include: - Su Poer (002032) with a net inflow of 3.66 million yuan from institutional investors [3] - Jiu Yang Co., Ltd. (002242) with a net inflow of 3.49 million yuan from institutional investors [3]

Group 1 - The core viewpoint of the news is that Kaineng Health has shown a positive stock performance with a year-to-date increase of 13.58% and a recent uptick of 2.09% in stock price, indicating investor confidence [1][2] - As of November 6, Kaineng Health's stock price is reported at 6.85 CNY per share, with a market capitalization of 4.189 billion CNY and a trading volume of 71.29 million CNY [1] - The company has experienced a net inflow of main funds amounting to 9.423 million CNY, with significant buying activity from large orders [1] Group 2 - For the period from January to September 2025, Kaineng Health achieved operating revenue of 1.356 billion CNY, reflecting a year-on-year growth of 8.10%, and a net profit attributable to shareholders of 95.3532 million CNY, up 13.29% year-on-year [2] - Kaineng Health has distributed a total of 694 million CNY in dividends since its A-share listing, with 283 million CNY distributed over the past three years [3] Group 3 - Kaineng Health's main business involves the research, manufacturing, sales, and service of health-related water products for both residential and commercial use, with revenue composition being 61.31% from terminal business and services, and 37.24% from intelligent manufacturing and core components [1] - The company is categorized under the household appliances industry, specifically in small appliances and cleaning small appliances, and is associated with concepts such as small-cap stocks, gene sequencing, wastewater treatment, energy conservation, and medical beauty [1]

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company's revenue met expectations, while profits fell short. For the first three quarters of 2025, the company achieved a revenue of 1.356 billion yuan, representing an 8% year-on-year growth. The net profit attributable to the parent company was 95 million yuan, a 13% year-on-year increase, but the third quarter saw a decline in net profit by 7% year-on-year [6][5] - The company is focusing on expanding its cell business as a second growth curve, planning to acquire related companies from Yuaneng Group to enhance its health industry ecosystem [6][5] Financial Data and Profit Forecast - Total revenue for 2025 is projected to be 1.796 billion yuan, with a year-on-year growth rate of 6.4%. The net profit attributable to the parent company is expected to be 118 million yuan, reflecting a 41.5% year-on-year increase [5][6] - The company’s gross margin is expected to remain stable at around 39% from 2025 to 2027, with a return on equity (ROE) projected to increase to 11.7% by 2026 [5][6] - The company has adjusted its profit forecasts for 2025-2027, now expecting net profits of 118 million yuan, 152 million yuan, and 162 million yuan respectively, with corresponding price-to-earnings ratios of 33, 26, and 24 times [6][5]